EMA wants comment on rule to identify API imports; FDA warns German devicemaker;

> The European Medicines Agency is giving drug manufacturers until June 1 to comment on its draft guidance for written confirmation of API imports from outside Europe, which it is introducing to protect against counterfeit drugs. Item

> The FDA has issued a warning letter to German device maker I.E.M. for an array of problems at its plant in Stolberg. Story

> The United States Pharmacopoeia (USP) will work with the South Korea Food and Drug Administration (KFDA) on quality standards for drug manufacturing. Item

> Major pharmaceutical manufacturers in Jammu, India, are asking the government to add infrastructure and educational opportunities in the area to help companies better compete in the world market. Story


Sponsored By Digital Pharma Europe

Fierce Pharma Marketing is excited to announce the first virtual Digital Pharma Europe!

This summit will profile best-in-class case studies and senior-level discussions from leaders who are innovating the way we look at the intersection of digital technologies and marketing in Europe.